Health Condition 1: R52- Pain, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients >18 years willing to take part and give written informed consent. 2. Patients with complains of nasal discharge, nasal obstruction, facial pain and decreased sense of smell for more than 12 weeks. 3. Patients with presence of bilateral moderate to large nasal polyps on Nasal Endoscopy.
Exclusion criteria
Exclusion criteria: 1. Patients not giving consent for our study. 2. Patients who have received medical treatment in last 4 months. 3. Patients who have undergone surgery in last 6 months. 4. Patients with contraindications and hypersensitivity to steroids. 5. Female patients who are pregnant, lactating or planning to become pregnant. 6. Patients with co-morbidities like Hypertension, Diabetes mellitus, Asthma, Tuberculosis, Epilepsy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in nasal obstruction score after treatmentTimepoint: Reduction in Visual Analog Symptom score in follow up at 3 weeks and 2 months from baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in Nasal Endoscopic and CT Scan Nose and Paranasal sinuses score after treatmentTimepoint: Reduction in Lund and Mackay scoring of Nasal Endoscopy and CT Scan of Nose and Paranasal Sinuses in follow up at 3 weeks and 2 months from baseline. | — |
Countries
India
Contacts
JAWAHARLAL NEHRU HOSPITAL AND RESEARCH CENTRE